Should pan out well for all involved. Otto get more revenue and a further leg up into their far North America prospects. Byron have costs shared. Seems like a 3 way win for all parties.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025